OKYO (OKYO Pharma) Total Current Assets: $4.64 Mil (As of Sep. 2025)


OKYO OKYO Pharma Ltd OKYO
23 GF Score
Price $1.69
! 3 Warning Signs
View Full Analysis

What is OKYO Pharma Total Current Assets?

OKYO Pharma OKYO +1.20% 23 Total Current Assets is $4.64 Mil as of Sep. 2025. GuruFocus rates OKYO with a GF Score™ of 23/100. The stock has 3 warning signs investors should review.

Total current assets includes Cash, Cash Equivalents, Marketable Securities, Total Receivables, Total Inventories, and Other Current Assets. OKYO Pharma's total current assets for the quarter that ended in Sep. 2025 was $4.64 Mil.

OKYO Pharma  (NAS:OKYO) Total Current Assets Explanation

In Ben Graham's calculation of liquidation value, inventory is only considered worth half of its book value, and accounts receivable is considered worth 75% of its value. Therefore the liquidation value is lower than calculated from total current assets.

OKYO Pharma's Liquidation Value for the quarter that ended in Sep. 2025 is

Liquidation value
= Cash, Cash Equivalents, Marketable Securities-Total Liabilities+(0.75 * Accounts Receivable)+(0.5 * Total Inventories)
=4.22-8.059+0.75 * 0+0.5 * 0
=-3.84

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

OKYO Pharma Total Current Assets Related Terms

OKYO Pharma Total Current Assets Historical Data

* Premium members only.

The historical data trend for OKYO Pharma's Total Current Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

OKYO Pharma Total Current Assets Chart

OKYO Pharma Annual Data
Trend Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25
Total Current Assets
Get a 7-Day Free Trial Premium Member Only Premium Member Only 6.99 4.30 5.20 1.54 3.68

OKYO Pharma Semi-Annual Data
Mar16 Sep16 Mar17 Sep17 Mar18 Sep18 Mar19 Sep19 Mar20 Sep20 Mar21 Sep21 Mar22 Sep22 Mar23 Sep23 Mar24 Sep24 Mar25 Sep25
Total Current Assets Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 1.54 2.83 3.68 4.64
OKYO
23GF Score
OKYO Pharma Ltd OKYO
Total Current Assets is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

OKYO Pharma Total Current Assets Calculation

Total Current Assets are the asset that can be converted to cash or used to pay current liabilities within 12 months.

OKYO Pharma's Total Current Assets for the fiscal year that ended in Mar. 2025 is calculated as

Total Current Assets=Cash, Cash Equivalents, Marketable Securities+Total Receivables+Total Inventories+Other Current Assets
=1.561+1.889+0+0.225
=3.68

OKYO Pharma's Total Current Assets for the quarter that ended in Sep. 2025 is calculated as

Total Current Assets=Cash, Cash Equivalents, Marketable Securities+Total Receivables+Total Inventories+Other Current Assets
=4.22+0.023+0+0.4
=4.64

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Total Current Assets is linked to the Current Ratio, which is the result of dividing total current assets by total current liabilities. It is frequently used as an indicator of a company's liquidity, its ability to meet short-term obligations.

Total Current Assets is also linked to Working Capital, Net working capital is calculated as Total Current Assets minus Total Current Liabilities.

Frequently Asked Questions Learn more about Total Current Assets →
What does a Total Current Assets of $4.64 Mil mean?
OKYO Pharma (OKYO) has a Total Current Assets of $4.64 Mil as of Sep. 2025. The total amount of assets with liquidity less than one year as recorded on a company's balance sheet. View historical data for OKYO Pharma and its competitors.
Is OKYO Pharma's Total Current Assets too high?
OKYO Pharma's current Total Current Assets is $4.64 Mil. Overall, OKYO Pharma has a GF Score™ of 23/100, reflecting its overall financial health beyond just this single metric.
How does OKYO Pharma's Total Current Assets compare to ENTX and HRTX?
OKYO Pharma's Total Current Assets of $4.64 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Current Assets for a Biotechnology company?
A good Total Current Assets depends on the Biotechnology industry context. However, Total Current Assets should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Current Assets mean?
A high Total Current Assets can signal that a stock is expensive relative to its fundamentals. The total amount of assets with liquidity less than one year as recorded on a company's balance sheet. View historical data for OKYO Pharma and its competitors. OKYO Pharma's current Total Current Assets is $4.64 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is OKYO Pharma stock overvalued right now?
OKYO Pharma (OKYO) has a current Total Current Assets of $4.64 Mil. The current Total Current Assets is $4.64 Mil. OKYO Pharma's overall GF Score™ is 23/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Current Assets calculated?
Total Current Assets is calculated from a company's financial statements. For OKYO Pharma (OKYO), the current Total Current Assets is $4.64 Mil as of Sep. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

OKYO Pharma Business Description

Address 14/15 Conduit Street, Floor 4, London, GBR, W1S 2XJ
OKYO Pharma Ltd is a biopharmaceutical company. The company is developing therapeutics to improve the lives of patients with inflammatory eye diseases and chronic pain. It offers solutions for various diseases such as Dry Eye Disease, Non-infectious Anterior Uveitis, Allergenic Conjunctivitis, Chronic Pain, and Ocular Pain.
23GF Score

Get the complete analysis for OKYO

Total Current Assets is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$1.69
Price